David B. Samadi, MD
Misuse of Radiation Therapy In Prostate Cancer Patients
14 oct. 2013 16h10 HE | RoboticOncology
New York, NY, Oct. 14, 2013 (GLOBE NEWSWIRE) -- In the progression of prostate cancer, some men require treatment that is more palliative than curative. Radiation therapy for prostate cancer is one...
David B. Samadi, MD
Erectile Dysfunction and Sex After Prostate Cancer
11 oct. 2013 16h08 HE | RoboticOncology
New York, NY, Oct. 11, 2013 (GLOBE NEWSWIRE) -- While the use of erectile dysfunction (ED) drugs such as Viagra (sildenafil) is vast, most men would prefer to be sexually potent without the assistance...
David B. Samadi, MD
New Studies: Robotic Prostate Surgery Safer
03 oct. 2013 15h48 HE | RoboticOncology
New York, NY, Oct. 3, 2013 (GLOBE NEWSWIRE) -- In a major independent prostate cancer treatment study, minimally invasive prostate surgery proved significantly safer than open retropubic surgery. Both...
David B. Samadi, MD
Coffee May Put Prostate Cancer to Sleep
18 sept. 2013 13h29 HE | RoboticOncology
New York, NY, Sept. 18, 2013 (GLOBE NEWSWIRE) -- Good news continues to percolate for coffee drinkers. New research reveals that drinking four cups of coffee per day may help men reduce the risk...
David B. Samadi, MD
Prostate Cancer Expertise in the U.S.
16 sept. 2013 09h56 HE | RoboticOncology
New York, NY, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Jamaican headlines recently highlighted a growing concern among urologists there about prostate cancer diagnosis. A prominent topic at the symposium of...
David B. Samadi, MD
Metformin Double Duty: Diabetes and Prostate Cancer
27 août 2013 14h57 HE | RoboticOncology
New York, NY, Aug. 27, 2013 (GLOBE NEWSWIRE) -- Researchers in Canada share promising news for men with type 2 diabetes and prostate cancer. Long-term use of metformin for blood sugar control may also...
David B. Samadi, MD
Prostate Cancer Diagnosis: Understanding Gleason Score and Disease Staging
22 août 2013 15h52 HE | RoboticOncology
New York, NY, Aug. 22, 2013 (GLOBE NEWSWIRE) -- A newly published prostate cancer study helps clarify the risk associated with watchful waiting and active surveillance. Researchers found that as...
David B. Samadi, MD
Prostate Cancer ADT: Kidneys and Hips At Risk
20 août 2013 14h45 HE | RoboticOncology
New York, NY, Aug. 20, 2013 (GLOBE NEWSWIRE) -- New York, NY - Two separate prostate cancer studies highlight the risks associated with androgen deprivation therapy (ADT) for both aggressive...
David B. Samadi, MD
Obesity Ups Prostate Cancer Risks Before and After Surgery
06 août 2013 12h59 HE | RoboticOncology
New York, NY, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Obesity and prostate cancer are two of the most prevalent conditions among U.S. men. One in six will be diagnosed with prostate cancer; one in three are...
David B. Samadi, MD
International Prostate Cancer Expert Joins Lenox Hill Hospital
31 juil. 2013 16h33 HE | RoboticOncology
New York, NY, July 31, 2013 (GLOBE NEWSWIRE) -- Joining Lenox Hill Hospital as Chairman of Urology, Chief of Robotic Surgery and Professor of Urology at Hofstra North Shore-LIJ School of...